Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122440725 | 12244072 | 5 | F | 20160321 | 20160719 | 20160406 | 20160721 | EXP | DK-TAKEDA-2016MPI002314 | TAKEDA | 0.00 | F | Y | 0.00000 | 20160721 | OT | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122440725 | 12244072 | 1 | PS | BLINDED Ixazomib | IXAZOMIB | 1 | Unknown | UNK | 208462 | CAPSULE | |||||||||
| 122440725 | 12244072 | 2 | SS | BLINDED Placebo | INVESTIGATIONAL PRODUCT | 1 | Unknown | UNK | 208462 | CAPSULE | |||||||||
| 122440725 | 12244072 | 3 | SS | MLN9708 | IXAZOMIB | 1 | Unknown | 4 MG, UNK | 208462 | 4 | MG | CAPSULE | |||||||
| 122440725 | 12244072 | 4 | SS | Thalidomide | THALIDOMIDE | 1 | Unknown | 100 MG, UNK | 0 | 100 | MG | ||||||||
| 122440725 | 12244072 | 5 | SS | Aciclovir | ACYCLOVIR | 1 | Unknown | 800 MG, UNK | 0 | 800 | MG | ||||||||
| 122440725 | 12244072 | 6 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 300 MG, UNK | 0 | 300 | MG | ||||||||
| 122440725 | 12244072 | 7 | SS | TAMIFLU | OSELTAMIVIR PHOSPHATE | 1 | Unknown | 75 MG, UNK | U | 0 | 75 | MG | |||||||
| 122440725 | 12244072 | 8 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 40 MG, UNK | U | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122440725 | 12244072 | 1 | Plasma cell myeloma |
| 122440725 | 12244072 | 2 | Plasma cell myeloma |
| 122440725 | 12244072 | 3 | Plasma cell myeloma |
| 122440725 | 12244072 | 4 | Plasma cell myeloma |
| 122440725 | 12244072 | 5 | Prophylaxis |
| 122440725 | 12244072 | 6 | Prophylaxis |
| 122440725 | 12244072 | 7 | Influenza |
| 122440725 | 12244072 | 8 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122440725 | 12244072 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122440725 | 12244072 | Hypersensitivity | |
| 122440725 | 12244072 | Influenza |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122440725 | 12244072 | 3 | 20160316 | 20160323 | 0 | |
| 122440725 | 12244072 | 4 | 20160316 | 20160325 | 0 | |
| 122440725 | 12244072 | 5 | 20160316 | 20160325 | 0 | |
| 122440725 | 12244072 | 6 | 20160316 | 20160325 | 0 | |
| 122440725 | 12244072 | 8 | 20160316 | 20160323 | 0 |